Clinical Trials on Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Sweden
Total 7 results
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, Bulgaria, Italy, Peru, Russian Federation, Canada, France, Germany, Hong Kong, Spain, Sweden, United Kingdom, Hungary, Poland, Ukraine, Czech Republic, India, Australia, Tunisia, Puerto Rico, Pakistan
-
Novartis PharmaceuticalsCompletedPurpura, Thrombocytopaenic, IdiopathicUnited Kingdom, Hong Kong, United States, Germany, Italy, Netherlands, Spain, Taiwan, Thailand, Canada, Denmark, Pakistan, Romania, Slovenia, Russian Federation, Slovakia, Sweden, Poland, China, New Zealand, Ukraine, Australia, Austria and more
-
Alexion Pharmaceuticals, Inc.RecruitingThrombotic MicroangiopathyUnited States, Italy, Spain, Korea, Republic of, United Kingdom, Belgium, Netherlands, Germany, Japan, Greece, Brazil, Israel, France, China, Sweden, Australia, Canada, Poland
-
AlexionCompletedAtypical Hemolytic Uremic SyndromeCanada, United Kingdom, France, Germany, Netherlands, Sweden, Italy
-
Alexion PharmaceuticalsCompletedAtypical Hemolytic Uremic SyndromeCanada, United Kingdom, France, Germany, Sweden, Netherlands, Italy
-
Alnylam PharmaceuticalsWithdrawnAtypical Hemolytic Uremic SyndromeSweden, Moldova, Republic of, Latvia, Lithuania, Estonia, Bosnia and Herzegovina, Canada, Georgia, Macedonia, The Former Yugoslav Republic of, Serbia
-
Alexion PharmaceuticalsTerminatedAtypical Hemolytic Uremic SyndromeFrance, Canada, United States, Belgium, Italy, United Kingdom, Netherlands, Australia, Austria, Germany, Sweden, Switzerland